DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lotrel (Amlodipine / Benazepril) - Adverse Event Reports - Life Threatening Events

 



Index of reports > Cases resulting in life threatening events (4)

     Dyspnoea (3)Renal Artery Stent Placement (1)Pleurisy (1)Concomitant Disease Progression (1)Gangrene (1)Haematotoxicity (1)Oedema Peripheral (1)Orthopnoea (1)Asthenia (1)Cardiac Failure Congestive (1)

Below is the selection of adverse event reports related to Lotrel (Amlodipine / Benazepril) that includes cases resulting in life threatening events.

Adverse event in 77 year old female receiving Lotrel (Amlodipine / Benazepril)

Reported by a individual with unspecified qualification from United States on 2007-10-02

Patient: 77 year old female

Adverse reactions / side effects: Renal Failure, Laboratory Test Abnormal, Dyspnoea, Renal Artery Stent Placement, Gait Disturbance, Feeling Abnormal, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Lotrel (Amlodipine / Benazepril)



Adverse event in 65 year old male receiving Lotrel (Amlodipine / Benazepril)

Reported by a physician from United States on 2007-04-25

Patient: 65 year old male, weighing 109.5 kg (240.9 pounds)

Adverse reactions / side effects: LIP Swelling, Angioedema, Dyspnoea, Respiratory Disorder, Gout, Drug Hypersensitivity, Lens Implant, Pleurisy, Urticaria, Swollen Tongue

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Lotrel
    Dosage: level 3
    Administration route: Oral
    Indication: Hypertension
    Start date: 2005-06-28
    End date: 2006-03-28

Lotrel
    Dosage: level 1
    Administration route: Oral
    Start date: 2005-05-02
    End date: 2005-06-02

Lotrel
    Dosage: level 2
    Administration route: Oral
    Start date: 2005-06-03
    End date: 2005-06-27

Cosopt

Ketorolac Tromethamine

Allopurinol
    Dosage: 300 mg, unk
    Administration route: Oral

Ofloxacin

Prednisolone

Other drugs received by patient: Aspirin; Avandia; Darvon-N; Hydrocodone; Acetaminophen; NPH Insulin; Insulin; Lasix; Metoprolol Succinate; Neurontin; Montelukast Sodium; Nitroglycerin; Simvastatin



Adverse event in 47 year old female receiving Lotrel (Amlodipine / Benazepril)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-21

Patient: 47 year old female, weighing 52.2 kg (114.8 pounds)

Adverse reactions / side effects: Phlebitis, Muscle Atrophy, Pain, Post Procedural Complication, Condition Aggravated, Appendicitis Perforated, Gangrene, Collapse of Lung, Haematotoxicity, Peritonitis, Complex Regional Pain Syndrome, Joint Sprain, Pleural Effusion

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
MS Contin
    Dosage: 1 tablet twice daily-bid- po
    Administration route: Oral
    Indication: Complex Regional Pain Syndrome
    Start date: 2000-08-20
    End date: 2007-02-20

Lotrel
    Dosage: 1 tab daily po
    Administration route: Oral
    Indication: Hypertension
    Start date: 2001-01-01
    End date: 2007-02-20



Adverse event in 72 year old female receiving Lotrel (Amlodipine / Benazepril)

Reported by a physician from United States on 2007-01-26

Patient: 72 year old female, weighing 83.0 kg (182.6 pounds)

Adverse reactions / side effects: Dyspnoea, Dyspnoea Paroxysmal Nocturnal, Bundle Branch Block Left, Concomitant Disease Progression, Cardiomegaly, Oedema Peripheral, Orthopnoea, Cough, Cardiac Failure Congestive

Adverse event resulted in: life threatening event

Suspect drug(s):
Lotrel (Amlodipine / Benazepril)

Other drugs received by patient: Cozaar; Norvasc

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009